Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes

Endocrine

Volumn 39, Issue 3, 2011, Pages 272-277

  Dilbaz, Berna ^a   Özkaya, Enis ^b   Cinar, Mehmet ^a   Cakir, Evrim ^c   Dilbaz, Serdar ^a  

^a Etlik Zubeyde Hanim Maternity and Women's Health Teaching and Research Hospital   (Turkey)

^b Department of Obstetrics and Gynecology   (Turkey)

^c DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cardiovascular disease risk; Carotid intima media thickness; Polycystic ovary syndrome

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; WAIST HIP RATIO;

EID: 79960023595     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9437-6     Document Type: Article

References (24)

1. L. J. Rajashekar, D. Krishna, M. Patil, Polycystic ovaries and infertility: our experience. Hum. Reprod. Sci. 1(2), 65-72 (2008)
2. J. K. Zawdaki, A. Dunaif, Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach, in Polycystic ovary syndrome, ed. by A. Dunaif, J. R. Givens, F. Haseltine, G. R. Merriam (Blackwell Scientific Publications, Boston, 1992), pp. 377-384
3. E. Carmina, R. A. Lobo, Do hyperandrogenic women with normal menses have polycystic ovary syndrome? Fertil. Steril. 71, 319-322(1999) (Pubitemid 29069911)
4. E. Carmina, R. A. Lobo, Polycystic ovaries in women with normal menses. Am. J. Med. 111, 602-606(2001) (Pubitemid 34088069)
5. J. R. Chang, Polycystic ovary syndrome: diagnostic criteria, in Polycystic ovary syndrome, ed. by R. J. Chang, J. J. Heindel, A. Dunaif (Marcel Dekker, New York, 2002), pp. 361-365
6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25(2004)
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Hum. Reprod. 19, 41-47(2004)
8. A. Dokras, Cardiovascular disease risk factors in polycystic ovary syndrome. Semin. Reprod. Med. 26(1), 39-44 (2008)
9. E. O. Talbott, J. V. Zborowski, J. R. Rager, M. Y. Boudreaux, D. A. Edmundowicz, D. S. Guzick, Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89, 5454-5461(2004) (Pubitemid 39518426)
10. R. C. Christian, D. A. Dumesic, T. Behrenbeck, A. L. Oberg, P. F. Sheedy 2nd, L. A. Fitzpatrick, Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88, 2562-2568(2003) (Pubitemid 36724424)
11. C. J. G. Kelly, A. Speirs, G. W. Gould, J. R. Petrie, H. Lyall, J. M. C. Connell, Altered vascular function in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 742-746(2002) (Pubitemid 34158246)
12. G. Paradisi, H. O. Steinberg, A. Hempfling, J. Cronin, G. Hook, M. K. Shepard, A. D. Baron, Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103, 1410-1415(2001) (Pubitemid 32220633)
13. C. J. Alexander, E. P. Tangchitnob, N. E. Lepor, Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Rev. Obstet. Gynecol. 2(4), 232-239 (2009)
14. E. Guastella, R. A. Longo, E. Carmina, Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil. Steril. 94(6), 2197-2201 (2010)
15. D. Wiltgen, P. M. Spritzer, Variations in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil. Steril. 94(6), 2493-2496 (2010)
16. R. S. Legro, V. D. Castracane, R. P. Kauffman, Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet. Gynecol. Surv. 59(2), 141-154 (2004) (Pubitemid 38140845)
17. M. Luque-Ramírez, C. Mendieta-Azcona, F. Alvarez-Blasco, H. F. Escobar-Morreale, Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum. Reprod. 22(12), 3197-3203 (2007) (Pubitemid 351696785)
18. M. Rizzo, K. Berneis, M. Hersberger, I. Pepe, G. Di Fede, G. B. Rini, G. A. Spinas, E. Carmina, Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum. Reprod. 24(9), 2286-2292 (2009)
19. J. C. Lovejoy, G. A. Bray, M. O. Bourgeois, R. Macchiavelli, J. C. Rood, C. Greeson, C. Partington, Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study. Clin. Endocrinol. Metab. 81(6), 2198-2203 (1996) (Pubitemid 26175947)
20. C. D. Christakou, E. Diamanti-Kandarakis, Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health 4(6), 583-594 (2008)
21. A. Y. Chang, C. Ayers, A. Minhajuddin, T. Jain, P. Nurenberg, J. A. De Lemos, R. A. Wild, R. J. Auchus, Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin. Endocrinol. 74(1), 89-96 (2010)
22. A. Karaer, S. Cavkaytar, I. Mert, U. Buyukkagnici, S. Batioglu, Cardiovascular risk factors in polycystic ovary syndrome. J. Obstet. Gynaecol. 30(4), 387-392 (2010)
23. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H. F. Escobar-Morreale, W. Futterweit, O. E. Janssen, R. S. Legro, R. J. Norman, A. E. Taylor, S. F. Witchel, Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91(2), 456-488 (2009)
24. I. Lambrinoudaki, Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome. Maturitas 68(1), 13-16 (2010)